Cargando…
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
The oestrogen induced pS2 protein was measured in the cytosol of 446 breast cancer samples by an immunoradiometric assay. The relationships between pS2 and several clinical and biological parameters were evaluated. pS2 was not correlated to age, pT and nodal status, while it was higher in pre- than...
Autores principales: | Gion, M., Mione, R., Pappagallo, G. L., Gatti, C., Nascimben, O., Bari, M., Leon, A. E., Vinante, O., Bruscagnin, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968537/ https://www.ncbi.nlm.nih.gov/pubmed/8347494 |
Ejemplares similares
-
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
por: Gion, M., et al.
Publicado: (1991) -
Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.
por: Dittadi, R., et al.
Publicado: (1993) -
Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
por: Dittadi, R., et al.
Publicado: (1991) -
446 To Stay or Not to Stay: Multidisciplinary Collaboration After NSF Funding
por: Mohammed, S., et al.
Publicado: (2023) -
A Randomized Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Complete Remission?
por: Nicoletto, M. O., et al.
Publicado: (2004)